GC Medical Science Corporation Stock: price and insider trades · South Korea
녹십자엠에스
1 insider bought €3,306 of shares over the last 90 days, the latest by 김연근, filed 28 Oct 2026.
Who traded when
BuySaleSince the insiders bought
- -18.9%Entry ₩3,615 · Close 03 Nov 2026 ₩2,930
- -18.9%Entry ₩3,615 · Close 03 Nov 2026 ₩2,930
- -13.9%Entry ₩4,725 · Close at T+365 ₩4,070
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 1,500 sharesShareKRXDART:20261028000026Canonical exit: 26 Jan 2027 (T+90)
- Other0DART
- 45,100 sharesKRXDART:20260701000571Canonical exit: 29 Sept 2026 (T+90)
- 3,000 sharesShareKRXDART:20260630000251Canonical exit: 28 Sept 2026 (T+90)
- 3,000 sharesShareKRXDART:20260630000262Canonical exit: 28 Sept 2026 (T+90)
- 2,500 sharesShareKRXDART:20260615000115Canonical exit: 13 Sept 2026 (T+90)
- 600 shares@ ₩3,521.000.0034% mcap100.0% of flowShareKRXDART:20260311003649Canonical exit: 7 Jun 2026 (T+90)
- 2,000 shares@ ₩3,419.750.011% mcap100.0% of flowShareKRXDART:20260311003639Canonical exit: 7 Jun 2026 (T+90)
- ●Executives0DART
- 1,000 sharesShareKRXDART:20260102000243Canonical exit: 2 Apr 2026 (T+90)
- 1,000 sharesShareKRXDART:20251104000058Canonical exit: 2 Feb 2026 (T+90)
- 1,000 sharesShareKRXDART:20251104000057Canonical exit: 2 Feb 2026 (T+90)
- 1,000 sharesShareKRXDART:20251030000172Canonical exit: 28 Jan 2026 (T+90)
- 1,000 sharesShareKRXDART:20251030000170Canonical exit: 28 Jan 2026 (T+90)
- ●Executives0DART
- 2,968,088 sharesKRXDART:20241018000344Canonical exit: 16 Jan 2025 (T+90)
- ShareKRXDART:20240610000237Canonical exit: 8 Sept 2024 (T+90)
- ShareKRXDART:20240510000111Canonical exit: 6 Aug 2024 (T+90)
- 2,968,088 sharesKRXDART:20230404002483Canonical exit: 3 Jul 2023 (T+90)
- ●Executives0DART
- 2,968,088 sharesKRXDART:20230221001494Canonical exit: 22 May 2023 (T+90)
- 10,000 shares@ ₩5,267.80100.0% of flowShareKRXDART:20230221000351Canonical exit: 17 May 2023 (T+90)
- 81,985 sharesKRXDART:20220404002847
- ●Executives0DART
25 of 29 declarations
About GC Medical Science Corporation
Four insiders bought between October 30 and November 4, 2025 at 녹십자엠에스 (GC Medical Science Corporation). Across the full history, 2 purchase filings are classed as clustered. Purchases come mostly from executives: 김연근 (대표이사) and 엄현 (상무) each have 4 filings, all purchases, of EUR 3,967 and EUR 1,225 respectively on March 9, 2026. The largest purchase with an amount, EUR 38,350, is by 사공영희 on February 16, 2023. This South Korean health care company, valued at KRW 96.3 billion and 47% held by insiders, counts 18 purchases for 1 sale, or 95% purchases among open-market trades. Three purchases carry an amount, EUR 43,542 in total with a median of EUR 3,967. 타임폴리오자산운용 has 4 purchases, 녹십자 (대량보유자) 1 purchase and 1 sale, and the company 녹십자엠에스 6 filings with neither purchase nor sale. 26 filings were published from March 9, 2021 to July 1, 2026: 8 in 2026, 5 in 2025, 4 in both 2022 and 2023, 3 in 2024, 2 in 2021. The last twelve months gather 12, 11 of them purchases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations